Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Experts recommend personalized treatment plans for alopecia areata, using corticosteroids and minoxidil for mild cases, and stronger medications for severe cases.

Early recognition and management of connective tissue diseases like lupus are crucial in young patients.

Early treatment with corticosteroids and immunosuppressants is crucial for managing Vogt-Koyanagi-Harada disease.

People with alopecia who are more resilient tend to feel less stressed.

Low-dose oral minoxidil may help with various hair loss types, but more research is needed.

Stem-cell therapy shows promise for skin conditions but needs more research.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

COVID-19 can cause long-term skin problems and has changed how skin doctors work.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Lupus can cause hair loss and nail changes, with treatments available for both.

COVID-19 and its vaccines can cause hair loss, which is not serious and can improve with psychological support.

Stress can cause hair loss by affecting nerve-related hair growth, and noradrenaline might help prevent this.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

Alopecia areata involves immune response and gene changes affecting hair loss.

African American adults and non-White children experience more hair loss episodes than White patients with alopecia areata.

Early treatment of pediatric lupus-related eye issues is crucial to prevent vision loss.

The investigation found no work-related causes for employee hair loss at Equifax Payment Services, and the environment was not hazardous.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

EPDS and MS might share an immune-related cause.

A woman experienced severe symptoms, including hair loss, after a COVID-19 vaccine, suggesting a possible autoimmune reaction.

Accurate diagnosis is crucial for effectively treating severe alopecia and related symptoms.

Hashimoto thyroiditis is an autoimmune disease that can lead to an underactive thyroid and is treated with medication and sometimes diet changes or surgery.

The skin's bacteria might influence the development of a hair loss condition called alopecia areata.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Some skin diseases and anaemia are related, and treating the skin condition can often improve the anaemia.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.